Clinically Localized Prostate Cancer: AUA/ASTRO Guideline, Part I: Introduction, Risk Assessment, Staging, and Risk-Based Management

James A. Eastham(Memorial Sloan Kettering Cancer Center), Stephen A. Boorjian(Mayo Clinic), Phillip M. Pierorazio(University of Pennsylvania Health System), George Rodrigues(London Health Sciences Centre), Tony Crispino, Eric M. Horwitz(Fox Chase Cancer Center), Scott E. Eggener(University of California, Los Angeles), Gregory B. Auffenberg, Sean M. McBride(Memorial Sloan Kettering Cancer Center), Roger Chou(Brown University), Alicia K. Morgans(Dana-Farber Cancer Institute), Daniel W. Lin(University of Washington), John W. Davis(The University of Texas MD Anderson Cancer Center), Erin Kirkby(American Urological Association), William W. Wong(Mayo Clinic in Arizona), Daniel A. Barocas(Vanderbilt University Medical Center), Christopher J. Kane(University of California San Diego)
The Journal of Urology
May 10, 2022
10.1097/ju.0000000000002757
Cited by 462

Related Papers

What low back pain is and why we need to pay attention
|The Lancet|2018|4.7k
Management of Postoperative Pain: A Clinical Practice Guideline From the American Pain Society, the American Society of Regional Anesthesia and Pain Medicine, and the American Society of Anesthesiologists' Committee on Regional Anesthesia, Executive Committee, and Administrative Council
|Journal of Pain|2016|3.2k
Prevention and treatment of low back pain: evidence, challenges, and promising directions
|The Lancet|2018|2.5k
Stereotactic ablative radiotherapy versus standard of care palliative treatment in patients with oligometastatic cancers (SABR-COMET): a randomised, phase 2, open-label trial
|The Lancet|2019|1.9k
Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort study
|The Lancet|2020|1.8k